Jump to content

  • Set Your Location
  • Sign in or Enroll
Set Your LocationSet Your Location
  • Sign in or Enroll
    • Open I want to choose my medical group or hospital
    • Clear my location
Change Location
Sutter Health
  • Video Visits
  • Find Doctors
  • Find Locations
  • Treatments & Services
    • Video Visits
    • Find Doctors
    • Find Locations
    • Treatments & Services
    • COVID-19 Resources
    • Pay a Bill
    • Symptom Checker
    • Get Care Today
    • Health & Wellness
    • Classes & Events
    • Research & Clinical Trials
    • For Patients
    • About Sutter Health
    • Giving
    • Volunteering
    • Careers
    • News
    • For Medical Professionals
    • Other Business Services
Close Search
  • Home
  • Research
  • Cardiovascular Diseases
Content

Patients' medication-related experience of care is associated with adherence to cardiometabolic disease therapy in real-world clinical practice.

Description

Romanelli RJ, Huang Q, LaMori J, Doshi D, Chung S., Popul Health Manag. doi: 10.1089/pop.2017.0163. [Epub ahead of print], 2018 Mar 12

Abstract

Adherence to cardiometabolic disease (CMD) medications is typically suboptimal. This study sought to evaluate the relationship between patients' medication-related experiences of care and adherence to CMD therapy.

This study was conducted using electronic health records and administrative data from an ambulatory care setting. It included adult managed care beneficiaries with a prescription for CMD medications (antihyperlipidemic, antihypertensive, or antihyperglycemic agents) between 2010 and 2014, written ±14 days of an office encounter linked to a completed patient experience survey.

Outcomes were primary and overall adherence. Primary adherence was defined as ever filling a CMD medication and overall adherence as ≥80% days covered over 365 days among those with an initial fill. Survey items ("inclusion in treatment decisions" and "information about medications") are measured on a scale from 1 (very poor) to 5 (very good). Logistic regression was used to assess associations between ratings on each item (5 vs. <5) and primary or overall adherence. Eligibility criteria were met by 7368 patients; 5865 had ≥1 fill.

After adjusting for confounders, better patient experiences with "inclusion in treatment decisions" (adjusted odds ratio [OR]:1.16; P = 0.049) and "information about medications" (OR:1.22; P = 0.009) were associated with greater odds of overall adherence to therapy. No significant associations were found between patient experience and primary adherence. Better patient medication-related experience of care is associated with improved adherence to CMD therapy.

Efforts to include patients in treatment decision making and to provide better education on medications are simple, modifiable solutions to improve adherence and resultant outcomes of CMD treatment.

Pubmed Abstract

Pubmed AbstractOpens New Window

Associated Topics

  • Cardiovascular Diseases
  • Diabetes, Insulin Resistance and Metabolic Syndrome
  • Disease Management
  • Health Services
  • Medical Informatics

Related Publications

Dabigatran versus warfarin for atrial fibrillation in real-world clinical practice: a systematic review and meta-analysis.

Romanelli RJ, Nolting L, Dolginsky M, Kym E, Orrico KB.
Circ Cardiovasc Qual Outcomes. pii: CIRCOUTCOMES.115.002369. [Epub ahead of print]
2016 Jan 26

Patient-initiated electronic messages and quality of care for patients with diabetes and hypertension in a large fee-for-service medical group: results from a natural experiment.

McClellan SR, Panattoni L, Chan AS, Tai-Seale M.
Med Care. [Epub ahead of print]
2016 Jan 12

Precision lifestyle medicine: a new frontier in the science of behavior change and population health.

Ma J, Rosas LG, Lv N.
Am J Prev Med. pii: S0749-3797(15)00638-8. doi: 10.1016/j.amepre.2015.09.035. [Epub ahead of print]
2015 Dec 01

Commentary on Costello JM, et al. Predictions by clinicians of quality of life for children and adolescents with cardiac disease.

Patel M, Wilson SR.
In: Cabana M, ed. Year Book of Pediatrics 2016. Philadelphia, PA: Elsevier; 2015: 199-202. ISBN: 978-0-323-44293-0.
2015 Dec 01

Acceptability and feasibility of the 'DASH for Asthma' intervention in a randomized controlled trial pilot study.

Blonstein AC, Lv N, Camargo CA, Wilson SR, Buist AS, Rosas LG, Strub P, Ma J.
Public Health Nutr. 2015 Dec 10:1-11. [Epub ahead of print]
2015 Dec 10
The Sutter Health Network of Care
Expertise to fit your needs
Primary Care

Check-ups, screenings and sick visits for adults and children.

Specialty Care

Expertise and advanced technologies in all areas of medicine.

Emergency Care

For serious accidents, injuries and conditions that require immediate medical care.

Urgent Care

After-hours, weekend and holiday services.

Walk-In Care

Convenient walk-in care clinics for your non-urgent health needs.

  • Contact Us
  • Find Doctors
  • Find Locations
  • Request Medical Records
  • Make a Gift
Sign in to My Health Online

Billing and Insurance

  • Pay a Bill
  • Accepted Health Plans
  • Estimate Costs
  • Medicare Advantage

About Sutter

  • About Our Network
  • Community Benefit
  • Annual Report
  • News

Our Team

  • For Employees
  • For Medical Professionals
  • For Vendors
  • For Volunteers

Careers

  • Jobs at Sutter
  • Physician Jobs
  • Graduate Medical Education

Copyright © 2023 Sutter Health. All rights reserved. Sutter Health is a registered trademark of Sutter Health ®, Reg. U.S. Patent & Trademark office.

  • ADA Accessibility
  • Privacy
  • Do Not Sell My Personal Information
  • LinkedIn Opens new window
  • YouTube Opens new window
  • Facebook Opens new window
  • Twitter Opens new window
  • Instagram Opens new window
  • Glassdoor Opens new window

Cookie Policy

We use cookies to give you the best possible user experience. By continuing to use the site, you agree to the use of cookies. Privacy Policy Cookie Preferences

Privacy Policy Cookie Preferences